NeuroThera Labs Inc. (TSXV: NTLX) (the "Company" or "NeuroThera"), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd., has advanced its collaboration with ...

CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...

Naturally occurring chemicals in cannabis have been shown to reduce cholesterol–and the risk of deadly fatty liver disease, ...

A new study from the Hebrew University of Jerusalem suggests that non-intoxicating cannabis compounds CBD and CBG may help ...

Terri Snyder of Goddard was diagnosed with fatty liver disease in 2012 and needed a liver transplant. “The first time, they said the liver, it wasn’t a good liver,” she said. “The second time, I think ...

Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.

Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

Low testosterone in itself can cause a variety of health problems, but the addition of a poor diet can exacerbate certain conditions. Metabolic dysfunction-associated steatotic liver disease (MASLD) ...

Sorbitol, a common sugar alcohol used in zero-calorie foods and found naturally in some fruits, isn’t just a passive ...

In experiments on pigs, researchers found that some formula fats can strain the newborn liver far earlier than expected.

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.